Treatment challenges and survival analysis of human epidermal growth factor receptor 2-positive breast cancer in real world
Context: Advent of trastuzumab has brought tremendous changes in the survival of human epidermal growth factor receptor 2 (Her2)-positive breast cancer patients. Despite the availability of the drug, it is still out of reach for many patients. There is very limited real world data regarding treatmen...
Saved in:
| Main Authors: | Praveen Adusumilli, Meher Lakshmi Konatam, Sadashivudu Gundeti, Stalin Bala, Lakshmi Srinivas Maddali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=1;spage=22;epage=27;aulast=Adusumilli |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy
by: Stalin Bala, et al.
Published: (2016-01-01) -
Current treatment options for human epidermal growth factor receptor 2-directed therapy in metastatic breast cancer: An Indian perspective
by: Gupta Sudeep, et al.
Published: (2018-01-01) -
Triple-negative breast cancer: Pattern of recurrence and survival outcomes
by: Shyny Reddy Chintalapani, et al.
Published: (2019-01-01) -
Trastuzumab: A milestone in human epidermal growth factor receptor 2-positive breast cancer
by: Manikandan Dhanushkodi
Published: (2020-01-01) -
Ado-trastuzumab emtansine – The monoclonal drug conjugate in human epidermal growth factor receptor 2-positive breast cancer
by: Sandip Ganguly, et al.
Published: (2020-01-01)